ABT
Abbott Laboratories · Healthcare · Medical Devices
TECHSellZACKSBuy
R500#166 today
$97.50
+0.84% today · -3.74% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- ABT +0.84% on the last session vs SPY +0.74%: +0.1 pts of stock-specific move.
- Aftermath, rsi oversold (Sep 30): After its 17 oversold readings in the past 5 years, ABT typically gained 0.6% over the next day (median) and was higher 53% of the time; half the outcomes fell between -1.1% and +1.3%. An ordinary day: +0.0%. Among S&P 500 stocks after oversold readings, that ranks #52 of 496.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Key facts
- Market cap
- $168.7B
- Held by institutions
- 81.8%
- Short interest
- 1.3%
- 52-week range
- 81.97–135.24
- Analyst mean target
- —
- Next earnings
- Oct 21 BMO
- Forward P/E
- 16.1
Recent events
Earnings ▲
2Q2026 results: EPS $1.31 vs $1.28 expected beat +$0.03 (+2.6%); next session +10.7% (+11.2 vs SPY)